Phase 3
Completed N=405
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Source: ClinicalTrials.gov NCT01794741 ↗Enrolled (actual)
405
Serious AEs
0.3%
Results posted
Mar 2015
Primary outcomePrimary: Adverse Events Report — 124; 37 event
Summary
This is a 3 month safety study of Dymista Nasal spray in children aged 4 to 11 years with allergic rhinitis
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adverse Events Report |
124; 37 | — |
Eligibility Criteria
Inclusion Criteria
- Male and female subjects ≥ 4 years to 50% of entries
Data sourced from ClinicalTrials.gov (NCT01794741). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.